Stroke RehabilitationNCT04395209
Muscle Strength Loss In Stroke Individuals - Control Study
A study testing assesment in people with Stroke Rehabilitation, run by Pamukkale University at 1 site in Turkey (Türkiye).
Trial summary
ABSTRACT The muscle strength (MS) is necessary to overcome the resistance encountered during the activity. The present study aims to determine MS loss in stroke individuals (SI). 33 SI and 33 healthy individuals (HI) were included in this study. Read more about this study
- Who is it for?
- Ages 30 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Stroke Rehabilitation
- What is being tested?
- assesment
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 66 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 31 Jan 2017to 1 Jan 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- for patient with stroke
- Between 30-65 ages
- Diagnosed with stroke chronic stroke patients (diagnosed with a stroke at least 6 months ago)
- for healthy individuals
- 30-65 ages
- healthy individuals
Who cannot join
- patient with an additional neurological disease to stroke
- patients with orthopedic problems,
- patients with mental and communication impairments
- patients who scored more than 3 points for the Modified Rankin Scale for healthy individuals;
- who had active sporting life
Trial locations and contacts
1 site in 1 country.
About this study
ABSTRACT The muscle strength (MS) is necessary to overcome the resistance encountered during the activity. The present study aims to determine MS loss in stroke individuals (SI). 33 SI and 33 healthy individuals (HI) were included in this study. MS and handgrip force were assessed using a power track dynamometer and Jamar hand dynamometer, respectively. The total MS of the HI was calculated by summing the muscle strength of the trunk, lower and upper extremities. In the SI, the muscle strength of the trunk, unaffected upper and lower extremities were summed to calculate the total MS. To compare MS of unaffected sides (US) between groups, 27 SI who was dominant and not affected on the right side and 33 HI who was dominant on the right side were used.
- Conditions
- Stroke Rehabilitation
- Being tested
- assesment
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
assesmentOther
muscle strength assessment in stroke individuals
| Study group | Role | What they receive |
|---|---|---|
| stroke individuals | Experimental | Not described Receives: Other: assesment |
| healthy individuals | Active comparator | Not described Receives: Other: assesment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Muscle Strength Loss In Stroke Individuals - Control Study
muscle strength of stroke individuals was assesed by power track hand held dynamometer and The Jamar Hand dynamometer, And recorded in newton.
Measured: 24 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 May 2020
- Study start31 Jan 2017
- Primary completion16 Jan 2018
- Study completion1 Jan 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stroke RehabilitationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- individuals with stroke and healthy subject
- Masking
- None (open label)
- Enrolment
- 66 participants (actual)
Sponsor and investigators
- Lead sponsor
- Pamukkale University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Suat EREL, Pamukkale University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04395209
- Sponsor's protocol ID
- Pamukkale Uni
- Status last verified
- May 2020
- First submitted
- 12 May 2020
- Last updated
- 20 May 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 May 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Muscle Strength Loss In Stroke Individuals - Control Study
- ClinicalTrials.gov ID
- NCT04395209
- Acronym / sponsor ID
- Pamukkale Uni
- Conditions
- Stroke Rehabilitation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 66 participants (actual)
- Lead sponsor
- Pamukkale UniversityUniversity, hospital or other
- Study start
- 31 Jan 2017 (actual)
- Primary completion
- 16 Jan 2018 (actual)
- Study completion
- 1 Jan 2020 (actual)
- First posted
- 20 May 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
ABSTRACT The muscle strength (MS) is necessary to overcome the resistance encountered during the activity. The present study aims to determine MS loss in stroke individuals (SI). 33 SI and 33 healthy individuals (HI) were included in this study. MS and handgrip force were assessed using a power track dynamometer and Jamar hand dynamometer, respectively. The total MS of the HI was calculated by summing the muscle strength of the trunk, lower and upper extremities. In the SI, the muscle strength of the trunk, unaffected upper and lower extremities were summed to calculate the total MS. To compare MS of unaffected sides (US) between groups, 27 SI who was dominant and not affected on the right side and 33 HI who was dominant on the right side were used.
Study design
- Primary purpose
- Other
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- individuals with stroke and healthy subject
| Arm | Type | Receives |
|---|---|---|
| stroke individuals | Experimental | Other: assesment |
| healthy individuals | Active comparator | Other: assesment |
Who may qualify
- Ages
- 30 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- for patient with stroke
- Between 30-65 ages
- Diagnosed with stroke chronic stroke patients (diagnosed with a stroke at least 6 months ago)
- for healthy individuals
- 30-65 ages
Key exclusion criteria (5 listed)
- patient with an additional neurological disease to stroke
- patients with orthopedic problems,
- patients with mental and communication impairments
- patients who scored more than 3 points for the Modified Rankin Scale for healthy individuals;
- who had active sporting life
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| assesmentmuscle strength assessment in stroke individuals | Other | healthy individuals, stroke individuals |
Primary outcome
Muscle Strength Loss In Stroke Individuals - Control Study
Time frame: 24 week
muscle strength of stroke individuals was assesed by power track hand held dynamometer and The Jamar Hand dynamometer, And recorded in newton.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 May 2020.
- Individual participant dataSharing planned: No
Related trials for Stroke Rehabilitation
Recruiting
Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke
Stroke, Stroke (CVA) or Transient Ischemic Attack
Enrolling by invitation
Evaluation of an Adaptive Neurotechnology Based on Motor Imagery in Patients Who Suffered a Left Hemisphere Stroke
Stroke, Brain Computer Interface
Enrolling by invitationObservational study
Enhancing Resilience Among Patients With Stroke: Implementation of High Intensity Home-based Rehabilitation
Stroke, Stroke Rehabilitation
Active, not recruiting
Visual and Auditory Electromyography Biofeedback Among Stroke Patients
Stroke, Hemiplegia
Recruiting
Music Therapy for Rehabilitation in Post-stroke Non-fluent Aphasia: the Indian Adaptation
Stroke Rehabilitation, Aphasia, Broca
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing assesment in people with Stroke Rehabilitation, run by Pamukkale University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 May 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Muscle Strength Loss In Stroke Individuals - Control Study (time frame: 24 week). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2020; AzTrials last refreshed its copy on 30 Oct 2026.